Published Date: 02 Mar 2023
When the arteries supplying blood to the stomach and liver swell and burst, it is an emergency in which 50% of patients die before reaching the hospital. This "silent killer" situation, know...
Read Full NewsTechnique deemed safe and feasible for selected patients and better than other minimally invasive approaches
Cardiomyopathy risks interrupting cancer treatment, worsening prognosis
— News, features, and commentary about cancer-related issues
1.
The Effect of Common Steroids on Cancer Treatments.
2.
Genetics and therapy type determine second cancer risk after childhood treatment, study finds
3.
Never in a million years did I think I'd have to limit my chemotherapy.
4.
Fighting for others: How guilt and obligation drive desire for more intensive treatments in end-of-life cancer care
5.
Study finds primary-care doctors often overlook prostate cancer risk in Black men
1.
Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Programmable Cell-Based Therapies for Selective Elimination of Abnormal Hematopoietic Cell Populations
4.
Understanding Acute Myeloid Leukemia (AML) and Its Survival Rates
5.
Exploring the Causes and Treatments of Thrombocytopenia: A Comprehensive Guide
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
1.
Signs and Symptoms of Leukemia
2.
Navigating the Complexities of Ph Negative ALL - Part I
3.
Efficient Management of First line ALK-rearranged NSCLC - Part V
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation